VWF and COVID-19: COVID-19-associated coagulopathy is the result of an endotheliopathy characterized by augmented von Willebrand factor release, platelet activation, and hyper-coagulability, leading to the clinical prothrombotic manifestations of COVID-19 that can include venous, arterial, and microvascular thrombosis.